A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Caffeine
Test CodeCPT Codes
83520
Preferred Specimen
Serum (gold or red top tube)
Minimum Volume
Transport Container
Serum (gold or red top) Tube
Transport Temperature
Specimen Stability
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Methodology
Turbidimetric
Setup Schedule
Daily upon receipt
Report Available
Reference Range
5.0 - 15.0 ug/mL
Clinical Significance
Caffeine is a mild stimulant and a minor metabolite of theophylline. Both are classified as methylxanthines. Methylxanthines are used to control and prevent neonatal apnea. Premature infants receiving theophylline have significant levels of caffeine in their blood because they metabolize theophylline to caffeine. Because the theophylline concentration is a poor indicator of the serum caffeine level, both caffeine and theophylline should be measured in premature infants receiving theophylline. By doing so, the total methylxanthine level can be assessed, thus avoiding toxicity. In premature infants receiving theophylline, caffeine has a long half-life and is therefore easily accumulated. The caffeine half-life in infants varies from 30 to 200 hours. As the metabolism of premature infants matures during the first 3 to 6 months of life, their caffeine half-life reaches adult rates of 4 to 6 hours. The wide range seen in premature infants is due to individual variations in caffeine metabolism.